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Abstract: Improvements in Systematic Evolution of Ligands by EXponential enrichment (SELEX)
technology and DNA sequencing methods have led to the identification of a large number of active
nucleic acid molecules after any aptamer selection experiment. As a result, the search for the fittest
aptamers has become a laborious and time-consuming task. Herein, we present an optimized
approach for the label-free characterization of DNA and RNA aptamers in parallel. The developed
method consists in an Enzyme-Linked OligoNucleotide Assay (ELONA) coupled to either real-time
quantitative PCR (qPCR, for DNA aptamers) or reverse transcription qPCR (RTqPCR, for RNA
aptamers), which allows the detection of aptamer-target interactions in the high femtomolar range.
We have applied this methodology to the affinity analysis of DNA and RNA aptamers selected against
the poly(C)-binding protein 2 (PCBP-2). In addition, we have used ELONA-(RT)qPCR to quantify
the dissociation constant (Kd) and maximum binding capacity (Bmax) of 16 high affinity DNA and
RNA aptamers. The Kd values of the high affinity DNA aptamers were compared to those derived
from colorimetric ELONA performed in parallel. Additionally, Electrophoretic Mobility Shift Assays
(EMSA) were used to confirm the binding of representative PCBP-2-specific RNA aptamers in solution.
We propose this ELONA-(RT)qPCR approach as a general strategy for aptamer characterization, with
a broad applicability in biotechnology and biomedicine.
Keywords: aptamer; SELEX; in vitro selection; ELONA; ELASA; qPCR; RTqPCR; PCBP-2
1. Introduction
Aptamers are single-stranded (ss) DNA or RNA molecules that can bind with high affinity
and specificity to a desired target molecule [1]. They are isolated from a large library of synthetic
random oligonucleotides using an amplification-selection in vitro process termed Systematic Evolution
of Ligands by EXponential enrichment (SELEX) [2]. Aptamers adopt a specific three-dimensional
solution structure that depends on their sequence and the physicochemical features of the folding
buffer (including the temperature, ionic strength, and concentration of divalent cations). The selected
DNA and RNA aptamers are able to recognize and, eventually, alter the activity of their target
molecules by establishing non-covalent aptamer–target molecular interactions. The current SELEX
technology allows the generation of aptamers with high affinity and specificity for a broad range
of targets, including low molecular weight compounds, peptides, proteins, structured nucleic acids,
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macromolecular complexes, and even whole cells [3]. As a result, aptamers have being used in a
growing number of biotechnological and biomedical applications over the last decade [4].
Next generation sequencing (NGS) of DNA is currently replacing the traditional methods based on
the analysis of clonal sequences, which provides a significant information increase on the selected pools
of aptamers [5,6]. Consequently, a vast number of selected, putative aptamer sequences are obtained
at the end of any SELEX process and, therefore, the screening of those showing the highest affinity for
the target has become more complex and time-consuming. Sequence alignments can be performed
using a wide range of bioinformatics tools, such as Clustal Omega, Multiple Alignment using Fast
Fourier Transform (MAFFT), and T-Coffee [7,8], while others specifically devoted to the aptamer field,
including FastAptamer [6], AptaCluster [9], or AptaGUI [10], have recently been developed. Based on
their output, aptamer candidates can be grouped in various families or categories, further subject to
secondary structure prediction using web servers, such as RNAfold [11] or Mfold [12].
A considerable number of individual aptamer candidates (from dozens to even hundreds)
must be functionally screened for their binding affinity and specificity against the cognate target.
The quantitative measurement of the aptamer–target binding reaction is often calculated by means of
the dissociation constant of the aptamer (Kd) and its maximum binding capacity (Bmax). Over the last
two decades, several methods have been used to characterize the binding affinity of aptamers, all of
them showing merits and limitations. Among them, colorimetric or fluorescence-based techniques,
Electrophoretic Mobility Shift Assays (EMSA), or those depending on additional biophysical principles
(surface plasmon resonance, thermal shift assays, circular dichroism, or UV-vis melting profiles, to
name a few) are the preferred methodologies [13–15]. However, most of them are laborious and
unworkable for analysing large numbers of individual aptamers. Additionally, the above-mentioned
techniques have been optimized to characterize either DNA or RNA aptamers, but not both types of
molecules in parallel.
Therefore, simpler, faster, and cost effective methods are required for the functional
characterization of aptamers. Drolet and coworkers [16] developed a modification of the traditional
Enzyme-Linked Immuno Sorbent Assay (ELISA) [17] by using aptamers instead of antibodies, which
they termed Enzyme-Linked OligoNucleotide Assay (ELONA). The original method, also known
as Aptamer-Linked Immobilized Sorbent Assay (ALISA) [18] or Enzyme-Linked Aptamer Sorbent
Assay (ELASA) [19], employed a fluorescent or colorimetric readout and allowed the simultaneous
analysis of numerous aptamers. However, the use of fluorescence-labelled DNA or RNA aptamers
is an expensive option for the characterization of large populations. Apart from that, colorimetric
readout is easily adaptable to DNA aptamers (through biotin or digoxigenin labelling), but it is
less optimized for RNA aptamers (because of the inherent technical difficulties associated to RNA
labelling) [20–22]. Furthermore, colorimetric reactions generally show a limited sensitivity and require
additional, time-consuming recognition reactions involving either streptavidin or an anti-digoxigenin
antibody labelled with horseradish peroxidase (HRP) or alkaline phosphatase (AP) [23]. To overcome
such limitations, here, we combine the mid-range sample throughput potential of ELONA with
the sensitivity of SYBR green-based, real-time quantitative PCR(qPCR). The use of aptamers as
(RT)qPCR-amplifiable reporter molecules excludes the need for aptamer or target labelling, allowing
a straightforward assay with enhanced sensitivity. Hence, ELONA-qPCR and, for the first time,
ELONA-RTqPCR were used to functionally analyse DNA and RNA aptamers in parallel. This provides
a significant advance to the post-SELEX aptamer characterization.
In this work, the combined features of ELONA-(RT)qPCR were applied to the characterization
of nucleic acid populations obtained after 10 rounds of DNA and RNA aptamer selection performed
in parallel against poly(C)-binding protein 2 (PCBP-2) (Figure 1). PCBP-2 was chosen as the target
molecule for this study due to the biological relevance of this pleiotropic protein, for which aptamers
have not been selected before. Our experimental setup allowed the analysis of more than 50 DNA
and RNA individual aptamers, all of them obtained after molecular cloning and sequencing of their
respective last selection round. Thereafter, the aptamers showing the highest affinity to PCBP-2 were
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characterized by means of their Kd and Bmax calculation, and some of them were revealed as high
affinity molecular probes that could be used for the development of highly sensitive aptamer-based
biosensors or ‘aptasensors’. As a validation technique, colorimetric ELONA was used in parallel to
quantify the Kd values of the high affinity DNA aptamers. Additionally, EMSA was employed to
confirm that representative examples of the high affinity RNA aptamers were able to form complexes
with the target protein in solution.
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Figure 1. Schematic representation of the SELEX processes performed to select ssDNA and RNA
aptamers in parallel using PCBP-2 as the target molecule, coupled to the ELONA-(RT)qPCR
methodology developed for the functional characterization of the individual aptamers present at
the last SELEX round.
2. Results
2.1. DNA and RNA Aptamer Selection
Target PCBP-2 was expressed as a fusion protein with a polyhistidine (6xHis) tag at its N-terminal
end, thus allowing its immobilization onto Cu2+-coated polys yrene plate (Supplementary Figure S1),
as well s o beaded agarose derivatized with the ni rilotria etic acid chelatio moiety and loaded with
divalent nickel ions (Ni-NTA) used s a matrix for the selec ion s ep. After a counter-selection st p
using empty Ni-NTA agarose beads, 10 DN and RNA SELEX cycles were accomplished in parallel
(Figure 1) at 37 ◦C in s lec ion buffer (SB). Individual DNA and RNA aptamers were cloned and
sequenced in each of the two final populations (termed 05DS10 and 05RS10, respectively), rendering
26 DNA and 32 RNA molecular sequ nces (Supplementary Tables S1 and S2).
The nucleotide composition of a RNA selected aptamers (Supplementary Figure S2),
showed a bias towards pyrimidine nucleotides in both processes (58.8% and 58.2% of the DNA and
RNA sequenc s, respectively) as well as a pre ominance of T/C or U/C tracks. In turn, no rep ated
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sequences among the 58 individual aptamers were observed, with the exception of the DNA molecules,
05DS10-02 and 05DS10-03.
2.2. (RT)qPCR Calibration Curves
Before setting up the ELONA-(RT)qPCR methodology for the affinity assay and further
characterization of aptamers, qPCR and RTqPCR calibration curves were constructed, using SYBR
green as a fluorophore and the template molecules, D-ACTG and R-ACUG, respectively (see Materials
and Methods). They were chosen as non-biased templates to represent the whole set of DNA or
RNA aptamer molecules selected in our work, regardless of their sequence composition. As shown
in Figure 2, a linear range of seven orders of magnitude (with a correlation coefficient, R2, higher
than 0.99) was achieved for both DNA and RNA templates. The minimum quantity of template DNA
and RNA detected was in the attomolar range: 6.25 × 10−18 mol of DNA (corresponding to a Ct
value of 26.41) and 1.80 × 10−17 mol of RNA (Ct = 24.13). Then, using these calibration curves, the
amount of aptamer bound to PCBP-2 after the partition step of the last SELEX round was quantified
by interpolating the average Ct value obtained in the ELONA-(RT)qPCR experiments. The possibility
that shorter PCR or RT-PCR products could have resulted from skipping some of the ACTG or ACUG
repeats of such template molecules was discarded by analysing the amplification products by gel
electrophoresis (Supplementary Figure S3).
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Figure 2. Calibration curves obtained for the amplification of DNA (A) and RNA (B) templates
(molecules of D-ACTG and R-ACUG, respectively) using real time qPCR or RTqPCR, with SYBR green
as the fluorophore. Average threshold cycle (Ct) of three PCR replicas for each template concentration
is shown in the table inset.
2.3. Affinity Analyses Using ELONA-(RT)qPCR
The interest in developing ELONA-(RT)qPCR methodology was twofold. First, it was used to
assay, in a 96-well format, the affinity and specificity of the individual selected aptamers. With that
purpose, a fixed amount of PCBP-2 (10 pmol), or the same amount of bovine serum albumin (BSA, used
as a control of specificity), was immobilized onto Cu2+-coated polystyrene plates, further incubated
with 10 pmol of each individual DNA or RNA aptamer (Supplementary Figure S1A,C). Such a
methodology allowed us to analyse 25 DNA and 27 RNA individual aptamers (Figures 3 and 4).
Among them, 11 DNA and 9 RNA aptamers showed a higher binding capacity than both the final
population as a whole (05DS10 or 05RS10, respectively) and the initial random pools (D-M1-40 and
R-M1-40). All of them showed a high specificity for PCBP-2 with respect to BSA, which was more
evident in the case of RNA aptamers (Figure 4).
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Figure 3. Screening of the PCBP-2 binding affinity of the ssDNA aptamers selected after 10 rounds of
SELEX process, using ELONA-qPCR. Recovered aptamers were amplified by qPCR, and the Ct values
(see text for details) were interpolated within the previously constructed calibration curve (Figure 2A)
to quantify the amount of aptamer (pmol) bound to PCBP-2. The mean and standard deviation values
of three independent experiments are shown. The whole aptamer population present at the final SELEX
round (05DS10) and the random population used as the starting material for the selection process
(D-M1-40) were assayed in parallel.
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Figure 4. Screening of the PCBP-2 binding affinity of the RNA aptamers selected after 10 rounds of
the SELEX process, using ELONA-RTqPCR. The Ct values obtained for each experiment (see text and
Figure 3 legend for details) were interpolated using the corresponding calibration curve (Figure 2B).
The mean and standard deviation (not visible for the BSA data) values of three independent experiments
are shown. The whole aptamer population present at the final SELEX round (05RS10) and the random
population used as the starting material for the selection process (R-M1-40) were assayed in parallel.
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2.4. Determination of Kd and Bmax Using ELONA-(RT)qPCR
The second use of ELONA-(RT)qPCR assays was to quantify the binding constants, Kd and
Bmax, of those individual DNA and RNA aptamers showing the highest affinity in the previous assay.
Hence, 16 aptamers were chosen among those that revealed a high binding capability and specificity
for PCBP-2: 05DS10-01, 05DS10-02, 05DS10-05, 05DS10-12, 05DS10-18, 05DS10-21, 05DS10-22, and
05DS10-26 (DNA aptamers); 05RS10-04, 05RS10-09, 05RS10-11, 05RS10-18, 05RS10-19, 05RS10-30,
05RS10-32, and 05RS10-34 (RNA aptamers). The experiments involved the immobilization of 10 pmol
of PCBP-2 to a Cu2+-coated polystyrene plate and its incubation with a titration of each aptamer (from
4.06 to 520 nM, Supplementary Figure S1B) in SB.
The affinity curves obtained using the ELONA-(RT)qPCR approach (Figures 5 and 6) showed that
the best fit curve corresponded to a one site-specific binding model (with R2 values in the range of
0.92–0.99) in all cases, from which the values of Kd and Bmax were computed. In parallel, the molecules
used as negative controls (D-ACTG and R-ACUG) and the initial populations (D-M1-40 and R-M1-40)
could only be adjusted to a linear regression model, thus revealing unspecific binding to PCBP-2.
All the assayed aptamers showed Kd values in the nanomolar range: From 8.4 to 89.9 nM for DNA
aptamers and from 24.1 to 276.5 nM for RNA aptamers. In turn, the Bmax values were in the range of
4.9 × 10−5 to 2.0 × 10−5 pmol (DNA) and 1.7 × 10−5 to 1.2 × 10−4 pmol (RNA). Thus, the highest
affinity for PCBP-2 was achieved by a DNA aptamer (05DS10-21, showing Kd = 8.4 nM), while the
fittest RNA aptamer showed an affinity three times smaller (05RS10-09, with Kd = 24.1 nM). Regarding
the maximum binding capacity, the DNA selection process produced the best aptamer (05DS10-05,
showing Bmax = 2.0 × 10−4 pmol), almost two times higher than the RNA aptamer endowed with the
maximum PCBP-2 binding (05RS10-32, with Bmax = 1.2 × 10−4 pmol).
We investigated whether the qPCR and RTqPCR calibration curves used could differ when some of
these DNA or RNA aptamer sequences were amplified instead of the D-ACTG and R-ACUG templates.
The obtained calibration curves for the different DNA and RNA templates overlapped along a linear
range of six orders of magnitude (Supplementary Figure S4). This result discards a relevant effect of
the relative amplification efficiencies of individual DNA or RNA sequences. Consequently, it justifies
the use of D-ACTG and R-ACUG as non-biased sequences for screening the whole set of DNA or RNA
aptamer molecules selected in our work.
2.5. Secondary Structure Prediction of the High Affinity DNA and RNA Aptamers
The predicted secondary structure of the 16 aptamers was calculated using Mfold software [12]
for DNA aptamers (Supplementary Figure S5) or the Vienna RNA package [11] for RNA aptamers
(Supplementary Figure S6). Hairpin or bulge loops containing three or more consecutive pyrimidines
were detected in the variable region of four DNA aptamers (05DS10-12, 05DS10-18, 05DS10-21,
and 05DS10-22), as well as in six RNA aptamers (05RS10-09, 05RS10-11, 05RS10-18, 05RS10-19,
05RS10-30, and 05RS10-32). Interestingly, the fittest RNA aptamer (05RS10-09) showed a 12 nt-long
bulge containing five consecutive pyrimidines (5′-UUCUU-3′). Other high affinity RNA aptamers
(05RS10-11, 05RS10-30, and 05RS10-32) also showed 5-6 pyrimidine tracks in internal or hairpin loops
(5′-CUUCC-3′, 5′-UUUCU-3′, and 5′-UUUUCU-3′, respectively). These findings complement previous
results showing that the 5′-UCCCU-3′ pentanucleotide was the preferred RNA binding sequence to
PCBP-2 [24,25]. However, a correlation between the secondary structure of the selected aptamers
and their binding capacity was not obvious, and will be the subject of further studies in our group.
Among the 16 aptamers assayed, the highest predicted folding stability was shown by 05RS10-30, with
a minimum free energy (MFE) of –23.40 kcal/mol (Supplementary Figure S6).
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2.6. Colorimetric ELONA as an Alternative Technique to Analyse Selected DNA Aptamers
Colorimetric ELONA was set up to assess the overall reliability of the Kd values of high affinity
DNA aptamers. The obtained Kd values of the digoxigenin-labelled version of the eight DNA aptamers
previously analysed using ELONA-qPCR ranged from 9.9 to 109.5 nM (Supplementary Figure S7), a
nanomolar range similar to that previously obtained using ELONA-qPCR. However, the behaviour of
the individual aptamers (with the exception of 05DS10-02) was quantitatively different in both readouts,
likely due to the experimental variables involved in qPCR amplification and colorimetric detection.
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Figure 6. Characterization of the high affinity RNA individual aptamers present in the last SELEX
round, using ELONA-RTqPCR. Affinity curves (A) and derived Kd and Bmax values (B) of eight
selected RNA aptamers and their corresponding controls (R-ACUG and R-M1-40, see text and Figure 5
legend for details). The upper limit of the y axis in panel A was chosen to be the same as that in Figure 5,
to allow a direct comparison of the performance of ssDNA and RNA aptamers targeting PCBP-2.
2.7. Binding of RNA Aptamers to PCBP-2 in Solution
EMSA was performed to test, in different experimental conditions, the binding capability of some
RNA aptamers previously analysed by ELONA-RTqPCR. RNA-protein binding assays were carried
out in solution at room temperature, the labelled RNA aptamer concentration was kept constant
(1 nM), and PCBP-2 was titrated (concentration range of 0.1 to 27.1 nM). The results (Figure 7 and
Supplementary Figure S8) showed a dose-dependent increase of retarded complex formation of the
aptamers, 05RS10-09 and 05RS10-32, with an increasing concentration of PCBP-2. Interestingly, two
different conformations of the free aptamer, 05RS10-09, were detected (Figure 7A). In addition, two
retarded complexes were distinguished for each aptamer–protein combination (Figure 7A,B). In both
cases, the formation of a second retarded complex with an increasing concentration of PCBP-2 could
be due to the addition of more than one copy of either the RNA aptamer or the target protein to the
complex. This possibility will be the subject of further investigation by our group. In summary, these
results showed that the selected aptamers provide binding sites for PCBP-2 protein in solution.
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3. Discussion
Among the diverse set of molecules involved in the regulation of post-transcriptional pathways,
poly(C)-bi ding prot ins (PCBPs) are of special interest due to their role in translation initiation of some
viral RNAs [26]. In particular, the cap-independent translation initiation of picorn virus RNA genomes
is odulated by the assembly of ribonucleoprotein complexes (involving PCBPs and other host factors)
on a highly struct red RNA element located at the 5′ untranslated region (5′UTR) of the viral gen m ,
termed the internal ribosome entry site (IRES) [27–30]. PCBP-2 (also known as hnRNP E2 or CP-2), is
a member of th cellular heterogeneous nucl ar ribonucleoprotein (hnRN ) family, which is located
in the cell nucleus and cyt plasm. hnRNPs bind to cellular proteins and RNAs, mediating various
biological proc sses that include transcriptional regulation, mRNA stabilization, translational control,
and apoptotic program activ tion [31–33]. PCBP-2 contai s a triplet of K homology (KH) RNA-binding
domains, found in the protein component of the human heterogeneous nuclear ribonucleoprotein
K (hnRNP K) [34]. KH domains have been identified as nucleic acid (RNA and ssDNA) recognition
motifs in proteins that perform a wide range of cellular functions, including transcriptional and
translational regulation. Interestingly, PCBP-2 binds to a conserved UC-rich region (containing a
CCCUCCC motif) in the 3′-UTR of the androgen receptor (AR) mRNA, thus suggesting a role for
PCBP-2 in the modulation of AR mRNA stability and/or transl tion [26,35].
In this w rk, ssDNA and RNA aptamers against PCBP-2 were selected in parallel, using
identical experimental conditions and selection pressures (Figure 1). The lack of convergence found
towards a limited number of aptamer sequences after 10 rounds of in vitro selection could be due,
among other possibilities, to the above mentioned fact that PCBP-2 contains a triplet of KH nucleic
acid-binding domains [34], which likely correlated with a basal nucleic acid binding capacity along the
SELEX processes.
Therefore, the in vitro DNA and RNA selection processes performed exemplify the need for an
experimental approach that allows the screening of the binding affinity and specificity of the selected
aptamers, beyond their individual sequences or secondary structures. Assays that effectively quantify
apta er-target i teractions inclu e colorimetric ELONA [23], flow cytrometry [36], surface plasmon
reso ance (SPR) [37], isothermal titration calorimetry [38], EMSA [39], or capillary electrophoresis [40].
However, each assay shows some benefits and drawbacks, its suitability depending on both the target
features and the type of aptamers (i.e., DNA or RNA) selected [13–15]. A ditionally, most of these
techniques are laborious and/or time consuming, others are not cost effective, and some of them
require labelling of either the target or the aptamer. Conversely, these methodologies are not suitable for
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the analysis of a large number of DNA and RNA aptamers simultaneously. To overcome such technical
hitches, we agreed to make use of ELONA as a highly specific and potentially high-throughput assay, in
combination with real time PCR (qPCR or RTqPCR) as a quantitative readout instead of the traditional
colorimetric methods.
The ELONA-(RT)qPCR methodology here developed allowed us to assay 52 individual DNA and
RNA aptamers selected against PCBP-2, as well as to further analyse the 16 fittest ones, avoiding the
need for either target/aptamer labelling or secondary recognition reaction. Additionally, (RT)qPCR
amplification (using SYBR green as the fluorophore instead of specific fluorescent probes) provided
sensitive detection of both DNA and RNA aptamers (down to 6 attomol, Figure 2). A somewhat
similar qPCR-based readout was reported by Pinto et al. [41] to detect thrombin using DNA aptamers
in a sandwich format. These authors also applied their so called ‘apta-PCR’ to the detection of other
targets [42,43]. However, such an assay was not used to comparatively analyse a large number of
individual DNA aptamers. Furthermore, RNA aptamers had not been previously assayed using
RTqPCR-based methods.
Our method allows a mid-range sample throughput (up to 16 DNA and/or RNA aptamers can
be screened in triplicate in a 96-well plate), fast (the complete protocol lasts less than 4 h), and cost
effective (thanks to the use of standard well plates and conventional qPCR with SYBR green, avoiding
aptamer or target labelling) analysis of individual aptamers. The Kd and Bmax values of the selected
aptamers were quantified for RNA and DNA aptamers in this report (not calculated for DNA aptamers
in previous apta-PCR studies [41–43]). Additionally, several validation experiments were performed.
Firstly, colorimetric ELONA was used to measure the Kd values of the eight high affinity DNA
aptamers, which remain in the same range as that obtained by ELONA-qPCR. However, quantitative
differences detected using both readouts may be due to the experimental variables involved in each of
them, including the accessibility of the digoxigenin to the anti-digoxigenin antibody in the colorimetric
ELONA, which relies on the (unknown) solution structure of each assayed aptamer. In turn, the
RTqPCR-based method developed here allows the screening and analysis of a number of RNA
aptamers in parallel, avoiding the need for RNA labelling. Furthermore, the binding of representative
in vitro selected RNA aptamers to PCBP-2 in solution was confirmed by EMSA (Figure 7). We have also
analysed, in a preliminary study using atomic force microscopy (AFM) [44], the specific binding of a 5′
thiol-modified version of the DNA aptamer 05DS10-21 to recombinant PCBP-2 that includes a GST-tag
at its N-terminal end (purchased from Abnova, Taiwan). This allowed us to test the performance of a
novel biosensor platform based on aptamers bound to thiol-functionalized graphene.
4. Materials and Methods
4.1. Expression and Purification of PCBP-2
E. coli BL21(DE3) cells transformed with a plasmid expressing 6 × His-PCBP-2 [45] grown at
37 ◦C were induced with 0.5 mM IPTG for 2 h. Bacterial cell lysates were prepared in binding buffer
(20 mM NaH2PO4, 500 mM NaCl, 20 mM imidazole, 5 mM DTT) as described [46]. Cell debris were
eliminated by centrifugation at 12,000 g for 30 min at 4 ◦C. The lysate was loaded in His-GraviTrap
columns (HealthCare) and the recombinant protein was eluted using 500 mM imidazol. The mobility
of the eluted PCBP-2 was visualized on coomassie blue stained gels after electrophoresis. Proteins
were dialyzed against phosphate buffer, pH 6.8, 1 mM DTT, and stored at –20 ◦C in 50% glycerol.
4.2. DNA and RNA Selection Protocol
For each SELEX round (Figure 1), 50 pmol of PCBP-2 were diluted in selection buffer (SB,
composed of 100 mM NaCl, 6 mM MgCl2, and 100 mM HEPES pH 7.4) and immobilized onto
25 µL Ni-NTA agarose beads (ThermoFisher, Madrid, Spain) following the manufacturer’s guidelines.
Such complexes were used as the selection matrix for the SELEX processes. The designed ssDNA
library, termed M1-40, contained a pool of 76 nucleotides (nt)-long oligonucleotides showing a
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central randomized region of 40 nt flanked by two conserved, 18 nt-long primer-binding sequences:
5′-GCGGATCCAGACTGGTGT(N40)GCCCTAAAGACAAGCTTC-3′. This synthetic random DNA
library and the DNA primers used for nucleic acid amplifications were purchased (HPLC-purified)
from IBA Lifesciences.
The starting material for the in vitro selection consisted in, roughly, 10 copies of each molecule
present in the original M1-40 population. To prepare it, 80 pmol (equivalent to 4.8 × 1013 molecules) of
M1-40 were amplified by PCR using the forward primer, M1-F (5′-GCGGATCCAGACTGGTGT-3′),
and the reverse, 5′-phosphorylated primer M1-R-5′P (5′-GAAGCTTGTCTTTAGGGC-3′). Four cycles
of PCR reaction (96 ◦C for 30 s, 60 ◦C for 1 min, and 72 ◦C for 1 min) were performed in a final volume
of 1 mL, with 200 µM each dNTP and 0.05 U/µL Expand High Fidelity Polymerase (Roche) [47].
The reverse DNA strand was removed by enzymatic digestion using λ exonuclease (New England
Biolabs), through incubation at 37 ◦C for 30 min followed by the enzyme inactivation at 75 ◦C for
10 min. PCR and digestion cleanup was achieved using Amicon Ultra-0.5 mL Centrifugal Filters
(ThermoFisher).
The first SELEX round was carried out using 800 pmol (equivalent to 4.8 × 1014 molecules) of
the prepared ssDNA population, resuspended in 90 µL of SB, denatured at 95 ◦C for 10 min, and
renatured at 37 ◦C for 10 min. The folded ssDNA pool was added to 90 µL of selection matrix (Ni-NTA
agarose beads bound to PCBP-2) and incubated at 37 ◦C for 30 min. In the partition step, unbound
ssDNA was removed from the selection matrix by centrifugation at 16,000 g for 2 min and washing
twice with 250 µL of SB. Then, ssDNA–PCBP-2–bead complexes were resuspended in 90 µL of Milli-Q
water, and ssDNA was denatured and eluted by heating at 95 ◦C for 5 min. The amplification of
eluted ssDNA to start the next SELEX round was performed using 5 to 20 cycles (adjusted in each
SELEX round depending on the amount of ssDNA recovered) of assymetric PCR using a 100-fold
excess of the forward primer, M1-F, with respect to the reverse primer, M1-R-5′P. The PCR reaction
(96 ◦C for 30 s, 60 ◦C for 1 min, and 72 ◦C for 1 min) containing up to 1 pmol of template was
performed in a final volume of 50 µL, with 200 µM each dNTP and 0.05 U/µL Expand High Fidelity
Polymerase. The residual presence of the reverse DNA strand was removed by enzymatic digestion
using λ exonuclease as described above. To foster the isolation of high affinity aptamers, the stringency
of the SELEX process was increased by reducing the amount of ssDNA bound to the selection matrix
(and, thus the ssDNA:PCBP-2 ratio) from 800 pmol (round 1) to 80 pmol (rounds 2 to 10), as well as by
doubling the number of washing steps every two rounds. A counter-selection step (using Ni-NTA
agarose beads without any bound protein) was introduced before the first round to discard aptamers
that could have been selected against the inert matrix. The complete SELEX method consisted of 10
amplification-selection rounds.
In turn, for the selection of RNA aptamers, 80 pmol (4.8 × 1013 molecules) of M1-40 were PCR
amplified using the primer, M2-F (5′-TGTAATACGACTCACTATAGGGGCGGATCCAGACTGGTGT-3′,
which includes the T7 RNA polymerase promoter, in italics) and M1-R, in a 1 mL reaction with
4 cycles. Milli-Q water treated with DEPC was used in all the processes involving RNA. Thereafter, the
amplified product was in vitro transcribed (IVT) by T7 RNA polymerase (using the AmpliScribe™ T7
High Yield Transcription Kit, Epicentre). The resulting RNA pool was purified by ethanol precipitation.
As in the case of ssDNA aptamers, the first SELEX round was performed using 800 pmol of RNA
population renatured in 90 µL of SB. After incubation with 90 µL of selection matrix at 37 ◦C for 30 min,
the unbound RNA was removed by centrifugation and washing. RNA–PCBP-2–beads complexes were
resuspended and RNA was eluted as detailed above. The recovered aptamers were retro-transcribed
and amplified by one-step RT-PCR (with SuperScript® III and Platinum® Taq DNA Polymerase,
ThermoFisher) using M2-F and M1-R in a total volume of 100 µL (8 to 15 PCR cycles were used in each
SELEX round, depending on the amount of RNA recovered), followed by in vitro transcription of 2 µg
of the amplified DNA pool. Other experimental variables were the same as those described for the
ssDNA process.
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4.3. Molecular Cloning and Sequencing of Individual Aptamers
The individual aptamers present at the last round of DNA or RNA SELEX processes were cloned.
With that aim, the products of the PCR-amplified DNA (or RT-PCR-amplified RNA) were cloned
using the TOPO TA cloning PCR II Kit (ThermoFisher) and the recombinant plasmids were used to
transform One Shot Mach1-T1 (ThermoFisher) competent E. coli strain. Then, 26 DNA and 32 RNA
individual aptamers were sequenced by capillary electrophoresis using an ABI 3730xl DNA Analyzer
(ThermoFisher) and following standard protocols.
4.4. Real Time qPCR and RTqPCR
All reactions were carried out in a StepOnePlus Real-Time PCR System (ThermoFisher): qPCRs
were performed using KAPA SYBR FAST qPCR Master Mix (Sigma, Madrid, Spain), whereas RTqPCRs
were carried out with SuperScript™ III Platinum™ One-Step qRT-PCR Kit (ThermoFisher). Both kits
contained SYBR Green I dye (Sigma). The final volume of all the reactions was 10 µL, containing
4.7 µL of the DNA or RNA template. For the construction of the calibration curves, serial dilutions of
the template molecules of D-ACTG and R-ACUG (Figure 2) were used, ranging from 6.25 × 10−12 to
6.25 × 10−18 mol in DNA and 1.8 × 10−11 to 1.8 × 10−17 mol in RNA.
4.5. ELONA-(RT)qPCR for Affinity Analysis
ELONA-(RT)qPCR experiments were performed by attaching 10 pmol of PCBP-2 to three
contiguous wells of a Greiner Bio-OneTM 96-Well High Binding Standard ELISA microplate
(ThermoFisher) while three additional wells were used to attach the same amount of BSA as a
control of the specificity (Supplementary Figure S1A). The proteins were incubated (at 37 ◦C for
60 min, in SB) with 10 pmol of each individual ssDNA or RNA aptamer (100 nM concentration in
the final reaction volume of 100 µL). After three washing steps with SB to remove unspecific binding,
PCBP-2 or BSA-bound aptamers were denatured and eluted with water at 95 ◦C. Recovered aptamers
were then amplified by qPCR or RTqPCR in triplicate, and the retrieved Ct values (average of the
9 values obtained for each ELONA experiment) were interpolated within the corresponding, previously
constructed calibration curve (Figure 2) to quantify the amount of aptamer bound to PCBP-2. In parallel
with the individual aptamers assayed, the whole aptamer population of the last SELEX rounds (termed
05DS10 for the ssDNA SELEX and 05RS10 for the RNA process) as well as the initial random pool
(M1-40) were subject to ELONA-(RT)qPCR in control experiments.
4.6. ELONA-(RT)qPCR for the Functional Characterization of Aptamers
The individual aptamers showing binding ability to PCBP-2 higher than that of the last
SELEX round population and M1-40 starting library were subject to further analysis by means of
ELONA-(RT)qPCR. For that, PCBP-2 (10 pmol) was attached to each of the 96 wells of a Cu2+-coated,
high capacity 96-well plate and it was incubated (in triplicate) with eight increasing concentrations
(4.06, 8.13, 16.25, 32.50, 65, 130, 260, and 520 nM) of each individual aptamer. Therefore, four different
aptamers could be assayed in parallel in a single plate (Supplementary Figure S1B). All the ELONA
experiments were repeated in two independent plates, thus 6 wells were used for assaying each
aptamer concentration. After 60 min of incubation in SB at 37 ◦C and three washing steps in SB,
PCBP-2-bound aptamers (Supplementary Figure S1C) were denatured and eluted with ultra-pure
water at 95 ◦C. Recovered aptamers were amplified by (RT)qPCR. The average Ct values derived from
two independent amplifications (corresponding to 12 Ct values for each aptamer concentration) were
interpolated within the previously constructed calibration curves (Figure 2) to quantify the amount of
bound aptamer (pmol) corresponding to each (DNA or RNA) aptamer concentration initially incubated
in the ELONA.
In parallel, two molecules were designed and assayed as negative controls in the
ELONA-(RT)qPCR experiments, whose sequences contained 10 repeats of either ACTG
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(ssDNA aptamers) or ACUG (RNA aptamers) tetranucleotides in their central regions. They
were termed D-ACTG (5′-GCGGATCCAGACTGGTGT(ACTG)10GCCCTAAAGACAAGCTTC-3′)
and R-ACUG (5′-GGGGCGGAUCCAGACUGGUGU(ACUG)10GCCCUAAAGACAAGCUUC-3′),
respectively. Additionally, the initial random population of D-M1-40 (and its RNA version, R-M1-40:
5′-GGGGCGGAUCCAGACUGGUGU(N40)GCCCUAAAGACAAGCUUC-3′) was also used as a
reference. All the affinity curves obtained were adjusted to alternative binding models using GraphPad
Prism software, and those showing higher R2 values were selected to calculate the corresponding Kd
and Bmax parameters for each individual DNA or RNA aptamer.
4.7. Colorimetric ELONA for the Functional Characterization of ssDNA Aptamers
The eight previously assayed ssDNA aptamers, as well as the D-ACTG negative control, were
subject to further analysis by means of colorimetric ELONA. With that aim, PCBP-2 (10 pmol) was
attached to a Cu2+-coated, high capacity 96-well plate (Supplementary Figure S1B) and it was incubated
(in triplicate) with eight increasing concentrations (3.91, 7.81, 15.63, 31.25, 62.50, 125, 250, and 500 nM)
of each individual, 3′ digoxigenin-labelled ssDNA aptamer (IBA Lifesciences). All the ELONA
experiments were repeated in two independent plates, thus 6 wells were used for assaying each
aptamer concentration. After a 60 min incubation in SB at 37 ◦C and three washing steps in SB,
PCBP-2-bound aptamers were incubated for 60 min in SB with 100 µL anti-digoxigenin antibody
diluted 1:5000 and labelled with HRP (Roche), following the manufacturer’s instructions. The reaction
mixture was washed three times in SB, and a colorimetric reaction was developed by adding 100 µL
of 3,3′,5,5′-tetramethylbenzidine (TMB). After incubating the reaction for 10 min, it was stopped by
adding 100 µL of 2 M sulphuric acid. Absorbance at 450 nm was recorded and plotted to quantify the
amount of ssDNA aptamer bound to PCBP-2 that corresponds to each aptamer concentration initially
incubated in the ELONA. Then, Kd and Bmax values were calculated as explained above.
4.8. Electrophoretic Mobility Shift Assays (EMSA) of Aptamer–PCBP-2 Complexes
RNA aptamer synthesis was performed by in vitro transcription using T7 RNA polymerase.
With that purpose, the dsDNA template version of the RNA aptamers (0.5 µg/µl) was transcribed
in 40 mM Tris-HCl pH 7.9, 6 mM MgCl2, 50 mM DTT, 0.5 mM rNTPs (final volume 10 µL) at
37 ◦C for 2 h. Transcripts were uniformly labelled using α32P-CTP (500 Ci/mmol) and RNA was
separated from non-incorporated isotope using G-25 (HealthCare) spin columns. Labelled RNA was
extracted with phenol-chloroform, ethanol precipitated, and resuspended in TE to a concentration of
0.04 pmol/µl. RNA integrity was examined in 6% acrylamide 7 M urea denaturing gel electrophoresis,
as described [48]. Next, aptamer–PCBP-2 binding reactions were carried out at room temperature for
20 min, in 10 µL of binding buffer (40 mM Tris-HCl pH 7.5, 250 mM NaCl, 0.1 % (w/v) βME). Increasing
amounts of protein (0.1 to 27.1 nM) were incubated with a fixed concentration of 32P-labelled RNA
(about 103 cpm, 0.01 pmol) for 20 min at room temperature, as described [49]. Following the addition
of xylene cyanol buffer (10 mM Tris-HCl pH7.5, 48.5% Glycerol, 0.5% xylene cyanol), the samples were
subjected to non-denaturing 8.0% (29:1) acrylamide/bis-acrylamide gel electrophoresis. The gels were
run at 100 V for 4 h in 1X TBE buffer (90 mM Tris-HCl pH 7.5, 64.6 mM boric acid, 2.5 mM EDTA,
pH 8.4) at 4 ◦C. The 32P-labelled RNA and retarded aptamer–PCBP-2 complexes were detected by
autoradiography (for 16 h and 80 h, at –80 ◦C) of dried gels.
5. Conclusions
Here, we report the development and characterization of the first described DNA and RNA
aptamers against the protein, PCBP-2. From a technological point of view, we demonstrated the
usefulness and general applicability of the ELONA-(RT)qPCR approach for the functional analysis
of DNA and, noticeably, RNA aptamers. This methodology allows the quantification of their
kinetic constants, Kd and Bmax, in a label-free and cost-effective format. Therefore, we envisage
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the ELONA-(RT)qPCR approach as a general strategy for aptamer characterization, with a broad
applicability in the field of aptamer-based biosensors useful in biotechnology and biomedicine.
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